EP0203177A4 - Polypeptide und antikörper gegen entglykosilierte virale glykoproteine. - Google Patents

Polypeptide und antikörper gegen entglykosilierte virale glykoproteine.

Info

Publication number
EP0203177A4
EP0203177A4 EP19860900378 EP86900378A EP0203177A4 EP 0203177 A4 EP0203177 A4 EP 0203177A4 EP 19860900378 EP19860900378 EP 19860900378 EP 86900378 A EP86900378 A EP 86900378A EP 0203177 A4 EP0203177 A4 EP 0203177A4
Authority
EP
European Patent Office
Prior art keywords
polypeptides
viral glycoproteins
antibodies related
deglycosylated
deglycosylated viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19860900378
Other languages
English (en)
French (fr)
Other versions
EP0203177A1 (de
Inventor
John H Elder
Stephen Alexander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Publication of EP0203177A1 publication Critical patent/EP0203177A1/de
Publication of EP0203177A4 publication Critical patent/EP0203177A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1036—Retroviridae, e.g. leukemia viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/13011—Gammaretrovirus, e.g. murine leukeamia virus
    • C12N2740/13022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
EP19860900378 1984-11-29 1985-11-20 Polypeptide und antikörper gegen entglykosilierte virale glykoproteine. Withdrawn EP0203177A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US67600884A 1984-11-29 1984-11-29
US676008 1984-11-29

Publications (2)

Publication Number Publication Date
EP0203177A1 EP0203177A1 (de) 1986-12-03
EP0203177A4 true EP0203177A4 (de) 1987-04-28

Family

ID=24712837

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860900378 Withdrawn EP0203177A4 (de) 1984-11-29 1985-11-20 Polypeptide und antikörper gegen entglykosilierte virale glykoproteine.

Country Status (3)

Country Link
EP (1) EP0203177A4 (de)
JP (1) JPS62501263A (de)
WO (1) WO1986003224A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2590674B1 (fr) * 1985-11-25 1989-03-03 Inst Nat Sante Rech Med Nouveaux reactifs de diagnostic
DK155886D0 (da) * 1986-04-04 1986-04-04 Bo Arne Hofmann Vaccine og fremgangsmaade til fremstilling af denne
NZ220500A (en) * 1986-05-30 1991-05-28 Cambridge Bioscience Corp Recombinant felv polypeptide; vaccine and expression vectors
US5352449A (en) * 1986-05-30 1994-10-04 Cambridge Biotech Corporation Vaccine comprising recombinant feline leukemia antigen and saponin adjuvant
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
CA2360347C (en) 1998-12-31 2013-05-07 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
CA2634992C (en) 2001-07-05 2012-10-16 Novartis Vaccines And Diagnostics, Inc. Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
WO2003020876A2 (en) 2001-08-31 2003-03-13 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CA2615372A1 (en) 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
PT2610345E (pt) 2007-11-27 2016-01-11 Medicago Inc Partículas semelhantes ao vírus (vlps) da gripe recombinantes produzidas em plantas transgénicas que expressam hemaglutinina
AU2009267769B2 (en) 2008-07-08 2015-07-16 Medicago Inc. Soluble recombinant influenza antigens
EP2318530B1 (de) 2008-07-18 2016-06-22 Medicago Inc. Neues epitop zur immunisierung gegen influenzavirus
EP2411049B1 (de) * 2009-03-27 2020-01-15 Academia Sinica Verfahren und zusammensetzungen zur immunisierung gegen viren
CA2762042C (en) 2009-06-24 2012-11-20 Medicago Inc. Chimeric influenza virus-like particles comprising hemagglutinin
PT2480560T (pt) 2009-09-22 2018-04-03 Medicago Inc Método de preparação de proteínas derivadas de plantas
TWI537385B (zh) 2010-11-04 2016-06-11 中央研究院 產生具簡單醣基化之表面蛋白質之病毒顆粒的方法
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004327A1 (en) * 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus
WO1985002625A1 (en) * 1983-12-09 1985-06-20 Cetus Corporation Feline leukemia virus vaccine
EP0151475A2 (de) * 1984-02-03 1985-08-14 Juridical Foundation Japanese Foundation for Cancer Research Adult-T-Zell-Leukemiavirus-Antigenpolypeptid
EP0199301A1 (de) * 1985-04-19 1986-10-29 F. Hoffmann-La Roche Ag Rekombinantes Viren-Überzugsprotein assoziiert mit "Acquired Immune Deficiency Syndrome" (AIDS) und Verfahren zur Testung von AIDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5945124B2 (ja) * 1977-10-31 1984-11-05 セイコーエプソン株式会社 眼鏡用フレ−ム

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984004327A1 (en) * 1983-04-27 1984-11-08 Harvard College Method and products for detection of human t cell leukemia virus
WO1985002625A1 (en) * 1983-12-09 1985-06-20 Cetus Corporation Feline leukemia virus vaccine
EP0151475A2 (de) * 1984-02-03 1985-08-14 Juridical Foundation Japanese Foundation for Cancer Research Adult-T-Zell-Leukemiavirus-Antigenpolypeptid
EP0199301A1 (de) * 1985-04-19 1986-10-29 F. Hoffmann-La Roche Ag Rekombinantes Viren-Überzugsprotein assoziiert mit "Acquired Immune Deficiency Syndrome" (AIDS) und Verfahren zur Testung von AIDS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8603224A1 *

Also Published As

Publication number Publication date
JPS62501263A (ja) 1987-05-21
WO1986003224A1 (en) 1986-06-05
EP0203177A1 (de) 1986-12-03

Similar Documents

Publication Publication Date Title
EP0203177A4 (de) Polypeptide und antikörper gegen entglykosilierte virale glykoproteine.
GB2119311B (en) Composite components of sandwich construction
IL84270A0 (en) Nor-statine and nor-cyclostatine polypeptides
ZA859463B (en) Sandwich immunoassay
GB8602672D0 (en) Protein modification
JPS5753578A (en) Adhesive blend and composite structure
GB8408193D0 (en) Antibodies
GB2196634B (en) Monoclonal antibodies to hiv and related peptides
EP0163894A3 (en) Composite material
EP0164028A3 (en) Mullite-cordierite composite ceramic
GB8608897D0 (en) Polypeptide
EP0151475A3 (en) Adult t cell leukemia virus antigen polypeptide
DE3479671D1 (en) Improvements in or relating to antibody preparations
IL87730A0 (en) Peptides and antibodies
GB8629566D0 (en) Composite material
GB8415186D0 (en) Polypeptides
EP0168907A3 (en) Monocional antibodies recognizing i-thyroxine
ZA855648B (en) Recombinant factor viii-r
GB8510026D0 (en) Sandwich structure
GB8529759D0 (en) Polypeptide
PT86162A (en) Recombinant protein expression
GB8717753D0 (en) Composite material
GB8609376D0 (en) Composite material
GB8723507D0 (en) Polypeptide
GB8715737D0 (en) Polypeptide

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

17P Request for examination filed

Effective date: 19861110

A4 Supplementary search report drawn up and despatched

Effective date: 19870428

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19890531

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ALEXANDER, STEPHEN

Inventor name: ELDER, JOHN, H.